166 related articles for article (PubMed ID: 29709351)
21. The expression of a tumor suppressor gene JDP2 and its prognostic value in hepatocellular carcinoma patients.
Chen YL; Chan SH; Lin PY; Chu PY
Hum Pathol; 2017 May; 63():212-216. PubMed ID: 28315425
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness.
Tsujikawa H; Masugi Y; Yamazaki K; Itano O; Kitagawa Y; Sakamoto M
Hum Pathol; 2016 Apr; 50():24-33. PubMed ID: 26997435
[TBL] [Abstract][Full Text] [Related]
23. Expression and prognostic significance of golgiglycoprotein73 (GP73) with epithelial-mesenchymal transition (EMT) related molecules in hepatocellular carcinoma (HCC).
Bao YX; Cao Q; Yang Y; Mao R; Xiao L; Zhang H; Zhao HR; Wen H
Diagn Pathol; 2013 Dec; 8():197. PubMed ID: 24313979
[TBL] [Abstract][Full Text] [Related]
24. Loss of RhoGDI is a novel independent prognostic factor in hepatocellular carcinoma.
Li W; Wang H; Jin X; Zhao L
Int J Clin Exp Pathol; 2013; 6(11):2535-41. PubMed ID: 24228117
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
26. Expression of Wnt-5a and β-catenin in primary hepatocellular carcinoma.
Li P; Cao Y; Li Y; Zhou L; Liu X; Geng M
Int J Clin Exp Pathol; 2014; 7(6):3190-5. PubMed ID: 25031739
[TBL] [Abstract][Full Text] [Related]
27. Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma.
Xu M; Xie F; Qian G; Jing Y; Zhang S; Gao L; Zheng T; Wu M; Yang J; Wei L
BMC Cancer; 2014 Feb; 14():65. PubMed ID: 24495509
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma.
Kong J; Zhou X; Liu S; Jin T; Piao Y; Liu C; Lin Z
Int J Clin Exp Pathol; 2014; 7(6):3018-27. PubMed ID: 25031720
[TBL] [Abstract][Full Text] [Related]
29. The correlation between insulin-like growth factor II mRNA binding protein 3 expression in hepatocellular carcinoma and prognosis.
Chen LT; Lin LJ; Zheng LL
Hepatogastroenterology; 2013 May; 60(123):553-6. PubMed ID: 23159356
[TBL] [Abstract][Full Text] [Related]
30. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma.
Wu MT; He SY; Chen SL; Li LF; He ZQ; Zhu YY; He X; Chen H
BMC Cancer; 2019 Jun; 19(1):538. PubMed ID: 31164099
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
32. Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.
Yang Z; Sun B; Zhao X; Shao B; An J; Gu Q; Wang Y; Dong X; Zhang Y; Qiu Z
Int J Clin Exp Pathol; 2015; 8(4):4033-43. PubMed ID: 26097591
[TBL] [Abstract][Full Text] [Related]
33. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
[TBL] [Abstract][Full Text] [Related]
34. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
Zhang Y; Fan Y; Mei Z
Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Value of Ki67 Expression for Patients with Surgically Resected Hepatocellular Carcinoma: Perspectives from a High Incidence Area.
Bai K; Cao Y; Huang Q; Jiang Y; Lv L
Clin Lab; 2017 Feb; 63(2):355-364. PubMed ID: 28182353
[TBL] [Abstract][Full Text] [Related]
37. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.
Yin F; Han X; Yao SK; Wang XL; Yang HC
World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422
[TBL] [Abstract][Full Text] [Related]
38. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.
Guo X; Xiong L; Sun T; Peng R; Zou L; Zhu H; Zhang J; Li H; Zhao J
Diagn Pathol; 2012 Apr; 7():44. PubMed ID: 22515642
[TBL] [Abstract][Full Text] [Related]
39. Hepatoprotective effect of hesperidin in hepatocellular carcinoma: Involvement of Wnt signaling pathways.
Zaghloul RA; Elsherbiny NM; Kenawy HI; El-Karef A; Eissa LA; El-Shishtawy MM
Life Sci; 2017 Sep; 185():114-125. PubMed ID: 28754618
[TBL] [Abstract][Full Text] [Related]
40. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
